Vaccine against Helicobacter pylori: Inevitable approach (Q26752743)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

30 March 2020

title

Vaccine against Helicobacter pylori: Inevitable approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

Helicobacter pylori infectious disease

30 March 2020

main subject

Helicobacter pylori

0 references

1 reference

inferred from title

author

Amin Talebi Bezmin Abadi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

30 March 2020

author name string

Amin Talebi Bezmin Abadi

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

30 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

30 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

30 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

3150-3157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

Pathogenesis of Helicobacter pylori infection

30 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

23 years of the discovery of Helicobacter pylori: is the debate over?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

H pylori antibiotic resistance: prevalence, importance, and advances in testing

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. 1929

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Antibiotic treatment for Helicobacter pylori: Is the end coming?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Therapy of Helicobacter pylori: present medley and future prospective

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Probiotics for the treatment of Helicobacter pylori infection in children

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Helicobacter pylori: Emergence of a Superbug

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

High yield purification of Helicobacter pylori neutrophil-activating protein overexpressed in Escherichia coli

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Current Status and Prospects for a Helicobacter pylori Vaccine

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

At last, vaccine-induced protection against Helicobacter pylori

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

A win for the patient: Direct patient notification improves treatment rates of active Helicobacter pylori infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Treatment of Helicobacter pylori infection 2014.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Saccharomyces boulardii CNCM I-745 in different clinical conditions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Helicobacter pylori infection: new pathogenetic and clinical aspects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Practical treatment of Helicobacter pylori: a balanced view in changing times

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Microorganisms with claimed probiotic properties: an overview of recent literature.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Treatment of Helicobacter pylori infection: current status and future concepts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Strategy for the treatment of Helicobacter pylori infection.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Clinical application of probiotics in the treatment of Helicobacter pylori infection--a brief review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Helicobacter, Inflammation, and Gastric Cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Fighting Fire with Fire: Is it Time to Use Probiotics to Manage Pathogenic Bacterial Diseases?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Recent advances in Helicobacter pylori pathogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Whos Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Worldwide H. pylori antibiotic resistance: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Treatment of Helicobacter pylori infection 2010.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Probiotics in clinical practice: an overview

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Helicobacter pylori detection and antimicrobial susceptibility testing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Antibiotic-resistant H. pylori infection and its treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Current Consensus and Remaining Questions Regarding the Diagnosis and Treatment of Helicobacter pylori Infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Quadruple rescue therapy after first and second line failure for Helicobacter pylori treatment: comparison between two tetracycline-based regimens

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Probiotic Mechanism of Lactobacillus gasseri OLL2716 Strain against Helicobacter pylori

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Treatment of Helicobacter pylori Infection: A Review of the World Literature

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Vaccination against Helicobacter pylori urease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

A humble bacterium sweeps this year's Nobel Prize

31 May 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Pathogenesis of Helicobacter pylori Infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

High correlation of babA 2-positive strains of Helicobacter pylori with the presence of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Successful treatment of secondary Helicobacter pylori eradication for chronic immune thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Lactobacillus reuteri in the treatment of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Is there a nonbismuth quadruple therapy that can reliably overcome bacterial resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Helicobacter pylori diagnostics and treatment: could a lack of universal consensus be the best consensus?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Stable amoxicillin resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Alkyl hydroperoxide reductase: A candidate Helicobacter pylori vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co‐delivery of interleukin‐2 and B subunit heat‐labile toxin gene encoded plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Immunogenicity of Helicobacter pylori urease B protein and DNA vaccines in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

MovingHelicobacter pylorivaccine development forward with bioinformatics and immunomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

An international association between Helicobacter pylori infection and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V22.I11.3150

Antibiotic resistance of Helicobacter pylori: prevalence in one region in the southern Netherlands and implications for treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789989

Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota

28 November 2018

1 reference

12 December 2020

Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments

1 reference

12 December 2020

Helicobacter pyloriflagella: antigenic profile and protective immunity

1 reference

12 December 2020

Pathogenesis of Helicobacter pylori infection

1 reference

12 December 2020

Pathogenesis of Helicobacter pylori infection

1 reference

12 December 2020

[Treatment of Helicobacter pylori infection]

1 reference

12 December 2020

Why do we still have Helicobacter Pylori in our Stomachs

1 reference

12 December 2020

Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia

1 reference

12 December 2020

In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria

1 reference

12 December 2020

An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V22.I11.3150

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

30 March 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27003991 AND SRC:MED&resulttype=core&format=json

30 March 2020

PubMed publication ID

27003991

2 references